Cancellation of state registration. Prednisolone

March 28, 2017
Active substances:
Trade names:
ICD-10:
I.A15-A19.A15.8    Tuberculosis of other respiratory organs, confirmed bacteriologically and histologically
I.A15-A19.A17.0    Tuberculous meningitis (G01 *)
I.B15-B19.B17.1    Acute hepatitis C
I.B15-B19.B16    Acute hepatitis B
I.B15-B19.B18    Chronic viral hepatitis
I.B15-B19.B18.2    Chronic viral hepatitis C
II.C30-C39.C34.9    Malignant neoplasm of bronchus or lung, unspecified
II.C81-C96.C81    Hodgkin's disease [lymphogranulomatosis]
II.C81-C96.C90.0    Multiple myeloma
II.C81-C96.C91.0    Acute lymphoblastic leukemia
II.C81-C96.C92.0    Acute myeloid leukemia
III.D60-D64.D60    Acquired pure red cell aplasia (erythroblastopenia)
III.D60-D64.D61    Other aplastic anemia
III.D65-D69.D69.3    Idiopathic thrombocytopenic purpura
III.D65-D69.D69.5    Secondary thrombocytopenia
III.D70-D77.D70    Agranulocytosis
III.D80-D89.D86    Sarcoidosis
IV.E00-E07.E06    Thyroiditis
IV.E20-E35.E25    Adrenogenital disorders
IV.E20-E35.E27.1    Primary insufficiency of the adrenal cortex
IV.E20-E35.E27.4    Other and unspecified adrenocortical insufficiency
VI.G35-G37.G35    Multiple sclerosis
VI.G90-G99.G93.6    Edema of the brain
VII.H10-H13.H10.1    Acute atopic conjunctivitis
VII.H15-H22.H15.0    Sclerite
VII.H15-H22.H15.1    Episcleritis
VII.H15-H22.H16    Keratite
VII.H15-H22.H20.0    Acute and subacute iridocyclitis
VII.H15-H22.H20.1    Chronic iridocyclitis
VII.H30-H36.H30    Chorioretinal inflammation
VII.H43-H45.H44.1    Other endophthalmitis
VII.H46-H48.H46    Optic neuritis
IX.I00-I02.I00    Rheumatic fever without mention of involvement of the heart
IX.I00-I02.I01    Rheumatic fever with involvement of the heart
X.J30-J39.J30.1    Allergic rhinitis caused by pollen of plants
X.J30-J39.J30.2    Other seasonal allergic rhinitis
X.J40-J47.J45    Asthma
X.J40-J47.J46    Asthmatic status [status asthmaticus]
X.J60-J70.J63.2    Berylliosis
X.J80-J84.J82    Pulmonary eosinophilia, not elsewhere classified
XI.K50-K52.K50    Crohn's disease [regional enteritis]
XI.K50-K52.K51    Ulcerative colitis
XI.K50-K52.K52    Other non-infectious gastroenteritis and colitis
XII.L10-L14.L10    Pemphigus [pemphigus]
XII.L10-L14.L12    Pemphigoid
XII.L10-L14.L13.0    Dermatitis herpetiformis
XII.L20-L30.L20.8    Other atopic dermatitis
XII.L20-L30.L21    Seborrheic dermatitis
XII.L20-L30.L23    Allergic contact dermatitis
XII.L20-L30.L24    Simple irritant contact dermatitis
XII.L20-L30.L26    Exfoliative dermatitis
XII.L20-L30.L27    Dermatitis due to substances taken internally
XII.L40-L45.L40    Psoriasis
XII.L50-L54.L50    Hives
XII.L50-L54.L51.1    Bullous erythema multiforme
XII.L50-L54.L51.2    Toxic epidermal necrolysis [Lyell's]
XIII.M05-M14.M05    Seropositive rheumatoid arthritis
XIII.M05-M14.M07 *    Psoriatic and enteropathic arthropathies
XIII.M05-M14.M08    Juvenile [juvenile] arthritis
XIII.M05-M14.M10    Gout
XIII.M15-M19.M15    Polyarthrosis
XIII.M30-M36.M30    Nodular polyarteritis and related conditions
XIII.M30-M36.M32    Systemic lupus erythematosus
XIII.M30-M36.M33    Dermatopolymiositis
XIII.M30-M36.M34    Systemic sclerosis
XIII.M45-M49.M45    Ankylosing spondylitis
XIII.M65-M68.M65    Synovitis and tenosynovitis
XIII.M65-M68.M68.8 *    Other disorders of the synovium and tendons in diseases classified elsewhere
XIII.M70-M79.M70    Diseases of soft tissues associated with exercise, overload and pressure
XIII.M70-M79.M75.0    Adhesive shoulder capsulitis
XIII.M70-M79.M77    Other enteropathies
XIV.N00-N08.N00    Acute nephritic syndrome
XIV.N00-N08.N03    Chronic nephritic syndrome
XIV.N00-N08.N04    Nephrotic syndrome
XVIII.R10-R19.R11    Nausea and vomiting
XIX.T66-T78.T78.2    Anaphylactic shock, unspecified
XIX.T66-T78.T78.3    Angioedema
XIX.T80-T88.T80.6    Other serum reactions
XIX.T80-T88.T88.7    Pathological reaction to medication or medicines, unspecified
XXI.Z80-Z99.Z94    Presence of transplanted organs and tissues
Prednisolone, systemic diseases, autoimmune diseases, anaphylactic shock, allergic reactions, glucocorticosteroid

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N013537 / 01 from 05.03.2010 issued Pabianicki Pharmaceutical Plant Polfa JSC, Poland):

Prednisolone (trade name of the drug)

Prednisolone (international non-proprietary, or grouping, or chemical name medicinal product)

tablets, 5 mg (dosage form, dosage)

Pabianice Pharmaceutical Plant Polfa JSC, Poland 5 Marsz. J. Pilsudskiego Street, 95-200 Pabianice, Poland (name and address of the location of the manufacturer of the medicinal product)

on the basis of a filing by an authorized legal entity LLC Adamed Rasha, Russia of a request for the cancellation of state registration medicinal product.